Analysis of the key themes driving M&A activity reveals that ecommerce accounted for 2 medical devices deals announced in Q2 2024, worth a total value of $35m. The $35m acquisition of Nephron Pharmaceuticals by Sharps Technology was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q2 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, ecommerce-related deal activity decreased by 98% in Q2 2024 compared with the previous quarter’s total of $1.6bn and rose by 141% as compared to Q2 2023. Related deal volume remained flat in Q2 2024 versus the previous quarter and was 33% lower than in Q2 2023.
The top-ranked legal advisors supporting these M&A deals in H1 2024 were Darryl, Edward & Co; Hunter Taubman Fischer & Li; O'Melveny & Myers with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q2 2024 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.